S&P 500   3,757.94 (-0.67%)
DOW   30,008.77 (-0.88%)
QQQ   281.90 (-0.03%)
AAPL   146.46 (+0.04%)
MSFT   248.36 (-0.34%)
META   141.20 (+1.60%)
GOOGL   102.16 (+0.72%)
AMZN   120.88 (-0.06%)
TSLA   241.77 (+0.40%)
NVDA   133.32 (+0.93%)
NIO   14.97 (-6.67%)
BABA   85.03 (+0.76%)
AMD   68.88 (+1.38%)
T   15.46 (-2.95%)
MU   54.82 (+0.16%)
CGC   2.98 (-2.93%)
F   12.47 (-0.32%)
GE   66.25 (-1.76%)
DIS   101.06 (+0.26%)
AMC   7.34 (+0.14%)
PYPL   94.81 (+1.04%)
PFE   43.31 (-1.84%)
NFLX   242.66 (+2.50%)
S&P 500   3,757.94 (-0.67%)
DOW   30,008.77 (-0.88%)
QQQ   281.90 (-0.03%)
AAPL   146.46 (+0.04%)
MSFT   248.36 (-0.34%)
META   141.20 (+1.60%)
GOOGL   102.16 (+0.72%)
AMZN   120.88 (-0.06%)
TSLA   241.77 (+0.40%)
NVDA   133.32 (+0.93%)
NIO   14.97 (-6.67%)
BABA   85.03 (+0.76%)
AMD   68.88 (+1.38%)
T   15.46 (-2.95%)
MU   54.82 (+0.16%)
CGC   2.98 (-2.93%)
F   12.47 (-0.32%)
GE   66.25 (-1.76%)
DIS   101.06 (+0.26%)
AMC   7.34 (+0.14%)
PYPL   94.81 (+1.04%)
PFE   43.31 (-1.84%)
NFLX   242.66 (+2.50%)
S&P 500   3,757.94 (-0.67%)
DOW   30,008.77 (-0.88%)
QQQ   281.90 (-0.03%)
AAPL   146.46 (+0.04%)
MSFT   248.36 (-0.34%)
META   141.20 (+1.60%)
GOOGL   102.16 (+0.72%)
AMZN   120.88 (-0.06%)
TSLA   241.77 (+0.40%)
NVDA   133.32 (+0.93%)
NIO   14.97 (-6.67%)
BABA   85.03 (+0.76%)
AMD   68.88 (+1.38%)
T   15.46 (-2.95%)
MU   54.82 (+0.16%)
CGC   2.98 (-2.93%)
F   12.47 (-0.32%)
GE   66.25 (-1.76%)
DIS   101.06 (+0.26%)
AMC   7.34 (+0.14%)
PYPL   94.81 (+1.04%)
PFE   43.31 (-1.84%)
NFLX   242.66 (+2.50%)
S&P 500   3,757.94 (-0.67%)
DOW   30,008.77 (-0.88%)
QQQ   281.90 (-0.03%)
AAPL   146.46 (+0.04%)
MSFT   248.36 (-0.34%)
META   141.20 (+1.60%)
GOOGL   102.16 (+0.72%)
AMZN   120.88 (-0.06%)
TSLA   241.77 (+0.40%)
NVDA   133.32 (+0.93%)
NIO   14.97 (-6.67%)
BABA   85.03 (+0.76%)
AMD   68.88 (+1.38%)
T   15.46 (-2.95%)
MU   54.82 (+0.16%)
CGC   2.98 (-2.93%)
F   12.47 (-0.32%)
GE   66.25 (-1.76%)
DIS   101.06 (+0.26%)
AMC   7.34 (+0.14%)
PYPL   94.81 (+1.04%)
PFE   43.31 (-1.84%)
NFLX   242.66 (+2.50%)
LON:GSK

GSK - GSK Share Forecast, Price & News

GBX 1,324.40
-4.60 (-0.35%)
(As of 10/6/2022 04:45 PM ET)
Add
Compare
Today's Range
1,313.80
1,336
50-Day Range
1,296
1,743
52-Week Range
1,280.92
1,824.40
Volume
8.39 million shs
Average Volume
8.93 million shs
Market Capitalization
£53.87 billion
P/E Ratio
1,161.75
Dividend Yield
6.49%
Price Target
GBX 1,706.25

GSK MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
28.8% Upside
GBX 1,706.25 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.22
Upright™ Environmental Score
News Sentiment
0.21mentions of GSK in the last 14 days
Based on 19 Articles This Week
Insider Trading
Selling Shares
£261.85 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.44 out of 5 stars

GSK stock logo

About GSK (LON:GSK) Stock

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Stock News Headlines

GSK: Some Upside Likely (NYSE:GSK) - Seeking Alpha
JPMorgan Chase & Co. Reaffirms Neutral Rating for GSK (LON:GSK)
GSK's (GSK) Buy Rating Reaffirmed at Shore Capital
GSK (LON:GSK) Earns Equal Weight Rating from Barclays
GSK (GSK) Stock Moves -0.34%: What You Should Know
At GSK, women now hold both the CFO and CEO roles
Burberry Finance Chief Joins GSK As First Woman CFO
GSK picks Burberry's Brown as CFO - Reuters
GSK picks Burberry's Brown as CFO
See More Headlines
Receive GSK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

GSK Company Calendar

Last Earnings
7/29/2020
Ex-Dividend for 10/6 Dividend
8/18/2022
Today
10/06/2022
Dividend Payable
10/06/2022
Next Earnings (Estimated)
11/02/2022

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
90,096
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 1,706.25
High Stock Price Forecast
GBX 2,000
Low Stock Price Forecast
GBX 1,430
Forecasted Upside/Downside
+28.8%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
10 Analysts

Profitability

P/E Growth
8224.64
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£37.24 billion
Cash Flow
GBX 161.99 per share
Book Value
GBX 406.70 per share

Miscellaneous

Outstanding Shares
4,067,378,000
Free Float
N/A
Market Cap
£53.87 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Ms. Emma Natasha Walmsley (Age 52)
    CEO & Director
    Comp: $3.88M
  • Mr. Iain James Mackay (Age 60)
    CFO & Exec. Director
    Comp: $2.88M
  • Ms. Shobie Ramakrishnan
    Chief Digital & Technology Officer
  • Mr. Tony Wood
    Chief Scientific Officer
  • Ms. Sarah Elton-Farr
    Head of Investor Relations
  • Mr. James Ford
    Sr. VP & Group Gen. Counsel of Legal & Compliance
  • Ms. Sally Jackson
    Sr. VP of Global Communications & CEO Office
  • Ms. Diana Conrad
    Chief People Officer
  • Mr. David Simon Redfern (Age 56)
    Chief Strategy Officer
  • Mr. Philip C. Thomson
    Pres of Global Affairs













GSK Stock - Frequently Asked Questions

Should I buy or sell GSK stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GSK in the last year. There are currently 6 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GSK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares.
View GSK analyst ratings
or view top-rated stocks.

What is GSK's stock price forecast for 2022?

10 brokerages have issued twelve-month price targets for GSK's shares. Their GSK share price forecasts range from GBX 1,430 to GBX 2,000. On average, they expect the company's share price to reach GBX 1,706.25 in the next twelve months. This suggests a possible upside of 28.8% from the stock's current price.
View analysts price targets for GSK
or view top-rated stocks among Wall Street analysts.

How have GSK shares performed in 2022?

GSK's stock was trading at GBX 1,606.60 at the beginning of 2022. Since then, GSK stock has decreased by 17.6% and is now trading at GBX 1,324.40.
View the best growth stocks for 2022 here
.

When is GSK's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our GSK earnings forecast
.

How were GSK's earnings last quarter?

GSK plc (LON:GSK) posted its earnings results on Wednesday, July, 29th. The company reported $56.90 earnings per share (EPS) for the quarter.

How often does GSK pay dividends? What is the dividend yield for GSK?

GSK declared a dividend on Wednesday, July 27th. Shareholders of record on Thursday, August 18th will be paid a dividend of GBX 16.25 per share on Thursday, October 6th. This represents a yield of 0.93%. The ex-dividend date of this dividend is Thursday, August 18th. This is a positive change from the stock's previous dividend of GBX 14. The official announcement can be accessed at this link.
Read our dividend analysis for GSK
.

Is GSK a good dividend stock?

GSK (LON:GSK) pays an annual dividend of GBX 0.94 per share and currently has a dividend yield of 6.49%. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 82.24%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for GSK.

What other stocks do shareholders of GSK own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GSK investors own include AstraZeneca (AZN), General Electric (GE), Royal Dutch Shell (RDSB), Vodafone Group Public (VOD), Intel (INTC), NVIDIA (NVDA), Johnson & Johnson (JNJ), AT&T (T), Barclays (BARC) and Gilead Sciences (GILD).

What is GSK's stock symbol?

GSK trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How do I buy shares of GSK?

Shares of GSK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is GSK's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,324.40.

How much money does GSK make?

GSK (LON:GSK) has a market capitalization of £53.87 billion and generates £37.24 billion in revenue each year.

How many employees does GSK have?

The company employs 90,096 workers across the globe.

How can I contact GSK?

GSK's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The official website for the company is www.gsk.com. The company can be reached via phone at +44-20-80475000.

This page (LON:GSK) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.